Literature DB >> 27296528

Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores.

G Y H Lip1,2, D A Lane3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27296528     DOI： 10.1111/jth.13386

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  20 in total

1.  Combination of Oral Anticoagulants and Single Antiplatelets versus Triple Therapy in Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome: Stroke Prevention among Asians.

Authors:  Anwar Santoso; Sunu B Raharjo
Journal:  Int J Angiol       Date:  2020-05-06

2.  Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.

Authors:  Monika Kozieł; Christine Teutsch; Valentina Bayer; Shihai Lu; Venkatesh K Gurusamy; Jonathan L Halperin; Kenneth J Rothman; Hans-Christoph Diener; Chang-Sheng Ma; Menno V Huisman; Gregory Y H Lip
Journal:  J Arrhythm       Date:  2021-07-10

3.  Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

Authors:  Amaya García-Fernández; Vanessa Roldán; José Miguel Rivera-Caravaca; Diana Hernández-Romero; Mariano Valdés; Vicente Vicente; Gregory Y H Lip; Francisco Marín
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

4.  Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis.

Authors:  Cen Wang; Ye Yu; Wengen Zhu; Jianhua Yu; Gregory Y H Lip; Kui Hong
Journal:  Oncotarget       Date:  2017-08-03

5.  Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department.

Authors:  David R Vinson; E Margaret Warton; Dustin G Mark; Dustin W Ballard; Mary E Reed; Uli K Chettipally; Nimmie Singh; Sean Z Bouvet; Bory Kea; Patricia C Ramos; David S Glaser; Alan S Go
Journal:  West J Emerg Med       Date:  2018-02-12

6.  Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.

Authors:  Joshua D Brown; Amie J Goodin; Gregory Y H Lip; Val R Adams
Journal:  J Am Heart Assoc       Date:  2018-03-07       Impact factor: 5.501

7.  Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation.

Authors:  José Miguel Rivera-Caravaca; Vanessa Roldán; María Asunción Esteve-Pastor; Mariano Valdés; Vicente Vicente; Gregory Y H Lip; Francisco Marín
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

Review 8.  2018 Korean Guideline of Atrial Fibrillation Management.

Authors:  Boyoung Joung; Jung Myung Lee; Ki Hong Lee; Tae Hoon Kim; Eue Keun Choi; Woo Hyun Lim; Ki Woon Kang; Jaemin Shim; Hong Euy Lim; Junbeom Park; So Ryoung Lee; Young Soo Lee; Jin Bae Kim
Journal:  Korean Circ J       Date:  2018-12       Impact factor: 3.243

9.  2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.

Authors:  Chern-En Chiang; Ken Okumura; Shu Zhang; Tze-Fan Chao; Chung-Wah Siu; Toon Wei Lim; Anil Saxena; Yoshihide Takahashi; Wee Siong Teo
Journal:  J Arrhythm       Date:  2017-06-27

10.  Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores.

Authors:  Marco Proietti; José Miguel Rivera-Caravaca; María Asunción Esteve-Pastor; Giulio Francesco Romiti; Francísco Marin; Gregory Y H Lip
Journal:  J Am Heart Assoc       Date:  2018-09-18       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.